TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Updated ACC/AHA guidelines published in March 2026 recommend coronary artery calcium scans for adults at borderline or intermediate risk when the decision about preventive therapy is uncertain. The test can help assess plaque, but the opinion article argues that payment systems have not caught up; the source does not establish a new Medicare coverage policy or confirm that Medicare pays $50,000 for every heart attack.
The American College of Cardiology and American Heart Association gave coronary artery calcium scans a more central role in their March 2026 prevention guidelines, recommending the test for some adults whose risk is borderline or intermediate and whose decision about preventive treatment remains uncertain. The change addresses how clinicians assess coronary artery disease, but the source article does not document a new Medicare coverage policy for the scan.
A coronary artery calcium, or CAC, scan is a short imaging test that detects calcified plaque in coronary arteries. The opinion article’s authors, cardiologists Arthur Agatston and Oren Mechanic, say it typically takes about 10 minutes, costs about $100, and uses a fraction of the radiation of a standard chest CT. Those figures are presented by the authors; actual prices and costs may vary.
The updated guidance recommends CAC testing when a clinician and patient remain uncertain about preventive treatment after considering a person’s risk. The scan can add evidence about plaque burden to assessments based on factors such as age, cholesterol, diabetes, blood pressure and smoking. A score of zero may support a lower risk classification, while a score above 100 may point toward preventive medication and lifestyle measures. Treatment decisions still depend on the patient’s circumstances and clinical discussion.
Agatston and Mechanic illustrate the issue with a patient they call Rob, whose name they say was changed. They report that the 52-year-old had a CAC score of 220, despite a standard calculator placing him in a low-risk category. The example is an account from the authors, not an independent study. Their article argues that scans have remained peripheral in practice partly because clinical tools, insurer coverage and medical routines have not incorporated individualized imaging as readily as conventional risk factors.
Guidance Moves Imaging Into Prevention
The guideline change could affect conversations about statins and other preventive measures for people whose risk estimates alone do not settle the question. CAC imaging detects evidence of coronary plaque rather than estimating risk only from common clinical factors. That may help some patients and clinicians weigh the potential benefits and downsides of treatment with more individualized information.
The authors frame the issue as a mismatch between prevention and emergency care, contrasting a scan they estimate at about $100 with a heart attack bill they cite as $50,000. Those figures are the article’s framing, not a verified Medicare payment comparison: the source provides no billing data, defined patient group or method for calculating either amount. The broader policy question is whether health plans, including Medicare, will cover CAC testing for eligible patients and how coverage affects access.
Access matters because a test paid out of pocket may be less available to people with limited resources. The authors also point to artificial intelligence that can identify calcium on chest CT scans performed for other reasons. They say this could flag people for further evaluation, but do not provide outcome data showing that this approach prevents heart attacks or reduces costs.
Products Worth Considering
OMRON Complete 2-in-1 Upper Arm Blood Pressure Monitor with EKG
Bowflex PR1000 Home Gym
OMRON VIVA 360+ Body Composition Monitor and Smart Scale
As an affiliate, we earn on qualifying purchases.
From Risk Scores to Plaque Imaging
For decades, clinicians have commonly used calculators based on factors including age, cholesterol, blood pressure, smoking and diabetes to estimate cardiovascular risk. Such tools estimate likelihood; they do not directly show whether coronary plaque is present. CAC scanning offers an imaging-based measure of calcified plaque that can add information when the treatment choice is not clear.
According to Agatston and Mechanic, evidence supporting the scan accumulated over more than three decades, while its place in national guidance remained limited. The March 2026 ACC/AHA update marks a change in how the test is positioned, not a guarantee that every patient should receive it or that insurance will pay. The authors also describe emerging AI methods to analyze calcium and soft plaque on existing scans; those uses are developing and are distinct from the guideline recommendation they discuss.
“The guidelines have finally caught up to the evidence supporting coronary artery calcium scans.”
— Arthur Agatston, MD, and Oren Mechanic, MD, MPH, in their MedPage Today opinion article
Coverage and Cost Evidence Remain Unclear
The source does not establish whether Medicare currently covers CAC scans, which beneficiaries might qualify, or whether the March guideline update changes reimbursement. It also does not substantiate the headline’s $50,000 figure with a Medicare claims analysis, explain whether that amount represents a billed charge or program payment, or compare it with the cost of preventing an event.
The article is an opinion piece, and its patient example does not establish how often CAC results change treatment or reduce heart attacks. It gives no trial results or population-level outcome data for AI-based analysis of existing scans. The effects of broader testing on access, treatment decisions, health outcomes and total spending remain uncertain from the material provided.
Coverage Decisions Will Shape Access
The next practical question for patients and clinicians is whether coverage policies and clinical workflows will reflect the March 2026 guideline recommendation. Readers considering a scan can ask their clinician whether they fit the group for whom the result could help resolve a preventive-treatment decision, and should check their plan for eligibility and out-of-pocket costs. The source does not announce a Medicare rule or a scheduled coverage decision.
Further evidence on outcomes and costs would be needed to assess the authors’ broader argument that paying for scans can prevent expensive emergencies. Research on AI analysis of existing CT images may also clarify whether opportunistic screening can identify people who benefit from follow-up. For now, the confirmed development is the change in guideline guidance; its effect on insurance payment and routine care has not been established by the source.
Key Questions
What changed in the 2026 guidelines?
According to Agatston and Mechanic, the March 2026 ACC/AHA guidelines gave CAC scans a more central role for adults at borderline or intermediate risk when the decision about preventive treatment remains uncertain.
Does Medicare pay for a CAC scan?
The supplied source does not confirm Medicare coverage, eligibility rules or reimbursement amounts. Patients should check current coverage with Medicare or their plan and discuss whether the test is appropriate with a clinician.
What does a CAC scan measure?
A CAC scan detects and measures calcified plaque in the coronary arteries. It can add information to conventional risk estimates, but a result is not a treatment decision on its own.
Does a score of zero mean someone cannot have a heart attack?
No such guarantee is established in the source. The authors say a score of zero can reclassify risk downward; patients should discuss what their individual result means with a qualified clinician.
Are AI-based calcium readings part of the guideline change?
The article discusses AI analysis of calcium visible on existing chest CT scans as a developing approach. It does not say that AI use is required by the guidelines or provide evidence that it reduces heart attacks.
Source: rss
